DarioHealth reassigns Oded Cohen from GM of MSK to SVP Strategy M&A and MSK

DarioHealth Corp.

Cohen relieved as General Manager of MSK; reassigned to Senior Vice President of Strategy M&A and MSK effective Nov 25, 2021.
Reassignment part of planned reorganization due to integration of Upright Technologies, acquired Feb 1, 2021.
No disagreements between Cohen and the company were cited as the reason for the change.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Oded Cohen

Senior Vice President of Strategy M&A and MSK

DRIO · DarioHealth Corp.

Effective: 2021-11-25
Filed: November 29, 2021, 6:59 PM ET

On November 25, 2021, Mr. Oded Cohen was relieved from his role as General Manager of MSK and he was reassigned to serve as Senior Vice President of Strategy M&A and MSK of DarioHealth Corp.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Oded Cohen changed role as Senior Vice President of Strategy M&A and MSK at DarioHealth Corp..

Action: reassigned
Role: Senior Vice President of Strategy M&A and MSK

Exact text from the filing

On November 25, 2021, Mr. Oded Cohen was relieved from his role as General Manager of MSK and he was reassigned to serve as Senior Vice President of Strategy M&A and MSK of DarioHealth Corp.

View on SEC.gov

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-21-144442

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.